Suppr超能文献

在多态性背景下:溶解度数据的准确测量与验证

In the Context of Polymorphism: Accurate Measurement, and Validation of Solubility Data.

作者信息

Vázquez Marrero Víctor R, Berríos Carmen Piñero, Dios Rodríguez Luz De, Stelzer Torsten, López-Mejías Vilmalí

机构信息

Department of Biology, University of Puerto Rico-Río Piedras Campus, San Juan, Puerto Rico 00931, United States.

Crystallization Design Institute, Molecular Sciences Research Center, University of Puerto Rico, San Juan, Puerto Rico 00926, United States.

出版信息

Cryst Growth Des. 2019;19(7):4101-4108. doi: 10.1021/acs.cgd.9b00529. Epub 2019 Jun 7.

Abstract

Solubility measurements for polymorphic compounds are often accompanied by solvent-mediated phase transformations. In this study, solubility measurements from undersaturated solutions are employed to investigate the solubility of the two most stable polymorphs of flufenamic acid (FFA forms I and III), tolfenamic acid (TA forms I and II), and the only known form of niflumic acid (NA). The solubility was measured from 278.15 to 333.15 K in four alcohols of a homologous series (methanol, ethanol, 1-propanol, -butanol) using the polythermal method. It was established that the solubility of these compounds increases with increasing temperature. The solubility curves of FFA forms I and III intersect at ~315.15 K (42 °C) in all four solvents, which represents the transition temperature of the enantiotropic pair. In the case of TA, the solubility of form II could not be reliably obtained in any of the solvents because of the fast solvent-mediated phase transformation. The solubility of the only known form of NA was also determined, and no other polymorphs of NA were observed. The experimental solubility data of FFA (forms I and III), TA (form I), and NA in these four solvents was correlated using the modified Apelblat and model equations. The correlated and experimentally determined solubility data obtained serves to (i) guide the accurate determination of the solubility for polymorphic compounds, (ii) assess the role of the solvent in mediating transformations, and (iii) provide a route to engineer advanced crystallization processes for these pharmaceutical compounds.

摘要

多晶型化合物的溶解度测量常常伴随着溶剂介导的相变。在本研究中,采用从欠饱和溶液进行溶解度测量的方法,来研究氟芬那酸(FFA晶型I和III)、托芬那酸(TA晶型I和II)以及尼氟酸(NA)唯一已知晶型的两种最稳定多晶型物的溶解度。使用变温法在四个同系醇(甲醇、乙醇、1-丙醇、1-丁醇)中测量了278.15至333.15 K范围内的溶解度。结果表明,这些化合物的溶解度随温度升高而增加。在所有四种溶剂中,FFA晶型I和III的溶解度曲线在约315.15 K(42℃)处相交,这代表了互变异构对的转变温度。对于TA,由于快速的溶剂介导相变,在任何一种溶剂中都无法可靠地获得晶型II的溶解度。还测定了NA唯一已知晶型的溶解度,未观察到NA的其他多晶型物。使用修正的Apelblat方程和 模型方程关联了FFA(晶型I和III)、TA(晶型I)和NA在这四种溶剂中的实验溶解度数据。所获得的关联溶解度数据和实验测定溶解度数据有助于:(i)指导准确测定多晶型化合物的溶解度;(ii)评估溶剂在介导相变中的作用;(iii)为设计这些药物化合物的先进结晶过程提供途径。

相似文献

7
One-solvent polymorph screen of carbamazepine.卡马西平的单溶剂多晶型筛选
Int J Pharm. 2008 Feb 4;348(1-2):3-9. doi: 10.1016/j.ijpharm.2007.06.053. Epub 2007 Oct 22.

本文引用的文献

4
Avoiding crystallization of lorazepam during infusion.避免劳拉西泮在输注过程中结晶。
Eur J Pharm Sci. 2011 Dec 18;44(5):621-6. doi: 10.1016/j.ejps.2011.10.010. Epub 2011 Oct 17.
6
Solubility of sparingly soluble drug derivatives of anthranilic acid.蒽羧酸类难溶性药物衍生物的溶解度。
J Phys Chem B. 2011 Mar 24;115(11):2547-54. doi: 10.1021/jp109905r. Epub 2011 Mar 2.
9
Infrared studies of the polymorphic states of the fenamates.非甾体抗炎芬那酸盐多晶型态的红外光谱研究
J Pharm Biomed Anal. 2005 Mar 9;37(3):509-15. doi: 10.1016/j.jpba.2004.11.009. Epub 2004 Dec 24.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验